| 英文别名 |
18,19-Dinorpregn-4-en-20-yn-17-ol,13-ethyl-, (17a)-(9CI);13-Ethyl-18,19-dinor-17α-pregn-4-en-20-yn-17-ol (Levo Norgestrel Impurity);13-ETHYL-18,19-DINOR-17A-PREGN-4-EN-20-YN-17-OL (LEVONORGESTREL IMPURITY D);13-Ethyl-18,19-dinor-17α-pregn-4-en-20-yn-17-ol
(Levo Norgestrel Impurity);(17a)-13-Ethyl-18,19-dinorpregn-4-en-20-yn-17-ol;13-Ethyl-18,19-dinor-17a-pregn-4-en-20-yn-17-ol (Levo Norgestrel IMpurity);EP Levonorgestrel Impurity D;(1R,3aS,3bR,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-ol;JPD9KM7FYK;13-Ethyl-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol;13-ETHYL-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-17-OL;18,19-DINORPREGN-4-EN-20-YN-17-OL, 13-ETHYL-, (17.ALPHA.)-;18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-, (17alpha)-;13-Ethyl-18,19-dinor-17Alpha-pregn-4-en-20-yn-17-ol (~90%) (Levo Norgestrel Impurity);SCHEMBL11858232;LEVONORGESTREL IMPURITY D [EP IMPURITY];32419-58-2;UNII-JPD9KM7FYK;13-Ethyl-18,19-dinor-17?-pregn-4-en-20-yn-17-ol (~90%);3-Deoxolevonorgestrel;Levonorgestrel impurity D [EP];18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-, (17a)- (9CI); 18,19-Dinor-17a-pregn-4-en-20-yn-17-ol, 13-ethyl-; 13-Ethyl-18,19-dinor-17a-pregn-4-en-20-yn-17-ol (3-Deoxolevonorgestrel); Levonorgestrel Imp. D |
